-

Agilent Wins Multiple Innovation Awards

Leading science industry publications recognize Agilent’s advances in mass spectrometry

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that both The Analytical Scientist and The Medicine Maker have honored the Agilent InfinityLab LC/MSD iQ system with 2019 Innovation Awards.

The award-winning mass spectrometer, introduced in June 2019, incorporates intelligent ‘designed-in’ innovations such as embedded sensors that monitor instrument health and provide early maintenance feedback.

Described by The Analytical Scientist as ‘a small, high-performance system that enables MS analysis without the requirement for extensive training,’ the Agilent InfinityLab LC/MSD iQ system is specifically designed for chemists and chromatographers, to be an easy-to-use mass selective detector that provides added specificity and selectivity.

“The pharma industry seems to be on the cusp of significant change,” said Stephanie Sutton, editor of The Medicine Maker. “Especially with the emergence of advanced medicines, such as cell and gene therapies, and new digital technologies with the potential to transform how the industry manufactures medicines – large and small. We’re proud to shine a light on the important contribution made by vendors to the manufacture of medicines and, ultimately, the treatment of patients.”

“Winning these two awards is especially gratifying, as it confirms the value of our continued emphasis on innovation,” said Monty Benefiel, Agilent vice president, and general manager of the company’s Mass Spectrometry Division. “It is our hope that the InfinityLab LC/MSD iQ system will help our customers do what they do best: improve the world around us.”

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Catherine Kaye
Agilent Technologies
+447775 410632
catherine.kaye@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

Catherine Kaye
Agilent Technologies
+447775 410632
catherine.kaye@agilent.com

More News From Agilent Technologies Inc.

Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2026 after the stock market closes on Monday, Nov. 23. The company will host a conference call to discuss the results at 1:30 p.m. PST the same day.To join the listen-only conference-call webcast, click the link on the Events section of Agilent’s Investor Relations website. A recording of the call will also be available on the website for 90 days.About Ag...

Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research

SANTA CLARA, Calif. & CHICAGO--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A), a global leader in analytical and clinical laboratory technologies, and the University of Chicago, one of the world’s leading research universities, today announced a scientific collaboration to establish the Agilent Center of Excellence (CoE) for Energy Materials Research. The Agilent CoE will be based at the University of Chicago Pritzker School of Molecular Engineering (UChicago PME) and will support the Ene...

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence

SANTA CLARA, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones. Proscia is a leading independent provider of enterprise digital pathology software, serving...
Back to Newsroom